Social media support groups to help teens and young adults quit vaping

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-arm pilot testing the feasibility and acceptability of the Quit the Hit Toolkit delivered through online social media groups. Community-based coaches are recruited and trained on the intervention, then they recruit and lead five-week vaping cessation groups for participants aged 13–21. Eligible participants must vape at least once per week, use social media most days, have a device with a camera to verify abstinence by photo, and reside in one of four states. The study focuses on training materials and implementation outcomes to inform larger controlled trials if the approach appears feasible and acceptable.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. English literacy
2. Age between 13-21 years (group participants) or 18+ (coaches, peer mentors)
3. Indicate they use social media "most" (\>= 4) days per week (group participants)
4. Have vaped at least once per week in the past 30 days (90 percent of participants) (group participants)
5. Access to a computer or mobile phone with photo capability to verify abstinence from vaping (group participants)
6. Indicate they are considering quitting or are interested in quitting with the next 6 months or within the next 30 days (group participants)
7. Currently reside in California, Minnesota, Oklahoma, or South Carolina

Exclusion Criteria:

1. No English literacy
2. Age under 13 or over 21 (group participants) or under 18 (coaches, peer mentors)
3. Insufficient social media use (3 or fewer days per week) (group participants)
4. Have not vaped at least once per week in past 30 days (group participants)
5. No access to computer or mobile phone with photo capability to verify abstinence from vaping (group participants)
6. Not considering or interested in quitting vaping in the next 30 days or 6 months (group participants)
7. Not a resident of California, Minnesota, Oklahoma, or South Carolina

Where it's running

• University of California, San Francisco
  San Francisco, California, United States Recruiting

Study contacts

• Principal investigator: Pamela M Ling, MD, MPH — University of California, San Francisco
• Study coordinator: Sarah Rosen, BA
• Email: quitthehit@ucsf.edu
• Phone: 415-502-0758

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• TUBSIS 2.0 — an online program to help adults reduce or quit smoking and vaping

  This program tests whether a free, anonymous, 4-week web-based course using mindfulness, self-compassion, and behavior-change techniques helps German-, English-, and Turkish-speaking adults who smoke or vape reduce or quit tobacco.

  Recruiting University of Zurich · Zurich · NCT07568483

• Varenicline plus enhanced TMS to help adults quit smoking and vaping

  This study tests whether adding active enhanced accelerated transcranial magnetic stimulation (aTMS) to varenicline helps adults 18–65 quit nicotine use more effectively than varenicline with sham stimulation.

  Recruiting Phase 4 Massachusetts General Hospital · Boston, Massachusetts · NCT07145866

• Varenicline to help adults stop vaping

  This trial tests whether the smoking-cessation pill varenicline helps adults who vape daily quit e-cigarettes.

  Recruiting at 2 sites Phase 2 Yale University · New Haven, Connecticut and 1 other locations · NCT07040566

• QuitVaping behavioral program with texting support to help teens stop vaping

  This trial will try QuitVaping plus extra texting to see if it helps teens aged 14–18 who vape nicotine quit more than standard education and referral alone.

  Recruiting Massachusetts General Hospital · Boston, Massachusetts · NCT06765291

• How people puff IQOS Iluma i vs IQOS 2.4 and how flavors feel

  This study tests how exclusive IQOS users puff the newer Iluma i versus the older 2.4, and whether preferred flavor affects puffing and sensory experience.

  Recruiting at 2 sites American University of Beirut Medical Center · Beirut, Beirut and 1 other locations · NCT07712887

• Do a single nicotine pouch affect cigarette craving and brain response to smoking cues

  This study tests whether a single 6 mg oral nicotine pouch can reduce craving and alter prefrontal brain responses to smoking cues in adults who smoke cigarettes.

  Recruiting University of Southern California · Los Angeles, California · NCT07698470

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.